VR Logo

Sierra Oncology Inc. (SRRA) download report


Healthcare | Biotechnology & Pharma Research

Sierra Oncology Inc. (SRRA) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.

IPO Date: 16-Jul-2015

Pres, CEO & Director: Dr. Stephen George Dilly M.B.B.S

Chief Financial Officer: Mr. Sukhi Jagpal CPA, CA, CBV, CPA, M.B.A., MBA

Listing: NASDAQ: SRRA

Country: United States

Headquarters: San Mateo, CA

Website: https://www.sierraoncology.com

Key Facts

Market cap: $1,340.87 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-102.67 Mln

Cash: $274.02 Mln

Total Debt: $5.62 Mln

Insider's Holding: 8.59%

Liquidity: Low

52 Week range: $14.91 - 55.19

Shares outstanding: 24,419,300

9 Years Aggregate:

  • CFO: $-358.58 Mln
  • EBITDA: $-428.44 Mln
  • Net Profit: $-491.02 Mln

Stock Performance

Time Period Sierra Oncology (SRRA) S&P BSE Sensex S&P Small-Cap 600
YTD152.76-8.71-17.92
1 month0.31-3.11-7.88
3 months66.87-7.30-13.56
1 Year174.480.48-17.16
3 Years33.2310.346.95
5 Years3.4411.436.30
10 Years--12.1010.29
As on 28-Jun-2022
Year Sierra Oncology (SRRA) S&P Small-Cap 600 S&P BSE Sensex
202135.6225.2721.99
202017.049.5715.75
2019-74.0620.8614.38
2018-64.41-9.705.87
2017150.3411.7327.91
2016-90.0924.741.95